The DOI matches its Crossref record.
Rare, Germline Mutation of KIT With Imatinib-Resistant Multiple GI Stromal Tumors and Mastocytosis
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cause of mastocytosis is mutational hyperactivation of KIT, the tyrosine kinase receptor for stem cell factor, which mast cell development and survival depend on. These mutations are typically somatic, and germline mutations are very rare. 149 , 150 , 151 , 152 , 153 , 154 , 155”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [155]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 10
- Casali PG, 2009, Ann Oncol, 20
- 10.1016/j.humpath.2007.03.001 · DOI
- 10.1053/hupa.2002.123545 · DOI
- 10.1126/science.279.5350.577 · DOI
- 10.3109/07357907.2010.494322 · DOI
- AV Hoffbrand, D Catovsky, EGD Tuddenham : Postgraduate Haematology (ed 5) 761– 782,2006 Oxford, United Kingdom Blackwell Publishing · DOI
- Patnaik MM, 2007, Arch Pathol Lab Med, 131, 784, 10.5858/2007-131-784-SMACCA · DOI
- 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D · DOI
- 10.1053/j.gastro.2005.06.060 · DOI · Paper page
- 10.1016/j.leukres.2005.08.015 · DOI · Paper page
Cited by
Sorted by citations
Mast cell ontogeny: From fetal development to life‐long health and disease
Chia, S. L., Kapoor, S., Carvalho, C., Bajénoff, M., & Gentek, R. (2023) · Immunological Reviews · doi:10.1111/imr.13191 · Cited by 60
Metadata
- Authors
- Speight, R. A., Nicolle, A., Needham, S. J., Verrill, M. W., Bryon, J., & Panter, S.
- Affiliations
- Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
- Queen Elizabeth Hospital, Gateshead, United Kingdom
- Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, United Kingdom
- West Midlands Regional Genetics Laboratory, Birmingham Women's National Health Service Foundation Trust, Birmingham, United Kingdom
- South Tyneside General Hospital, South Shields, United Kingdom
- Venue
- Journal of Clinical Oncology
- Published
- 2013-06-01
- Volume
- 31
- Issue
- 16
- Pages
- e245-e247
- ISSN
- 0732-183X
- 1527-7755
- Cited by
- 19
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rare, Germline Mutation of KIT With Imatinib-Resistant Multiple GI Stromal Tumors and Mastocytosis. https://app.cochat.ai/papers/10.1200/jco.2012.42.0133
- The paper
- Speight, R. A., Nicolle, A., Needham, S. J., Verrill, M. W., Bryon, J., & Panter, S. (2013). Rare, Germline Mutation of KIT With Imatinib-Resistant Multiple GI Stromal Tumors and Mastocytosis. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2012.42.0133
